Stefano Fontana, Simone Braggio, Mauro Corsi, Rob Riley, Chris Strock, Jenifer Bradley, Caterina Virginio & Paul Walker. 2023. The Handbook of Medicinal Chemistry. The Handbook of Medicinal Chemistry
533
596
.
Suman K. Chakravarti & Roustem D. Saiakhov. 2022. In Silico Methods for Predicting Drug Toxicity. In Silico Methods for Predicting Drug Toxicity
497
518
.
. 2021. Mutagenic Impurities. Mutagenic Impurities
233
268
.
Darren V. S. Green, Stephen Pickett, Chris Luscombe, Stefan Senger, David Marcus, Jamel Meslamani, David Brett, Adam Powell & Jonathan Masson. (2019) BRADSHAW: a system for automated molecular design. Journal of Computer-Aided Molecular Design 34:7, pages 747-765.
Crossref
Michael J. Burns, Martin A. OttAndrew TeasdaleSusanne A. StalfordVincent Antonucci, Jens-Christoph Baumann, Roland BrownElizabeth M. Covey-CrumpDavid ElderEric Elliott, Jared W. Fennell, Fabrice Gallou, Nathan D. Ide, Tetsuji Itoh, Guido Jordine, Jeffrey M. Kallemeyn, Dirk Lauwers, Adam R. Looker, Lucie E. Lovelle, Robert Molzahn, Didier Schils, Rolf Schulte Oestrich, Gregory W. Sluggett, Neil StevensonPere Talavera, Michael W. Urquhart, David L. Varie & Dennie S. Welch. (2019) New Semi-Automated Computer-Based System for Assessing the Purge of Mutagenic Impurities. Organic Process Research & Development 23:11, pages 2470-2481.
Crossref
Edwin John Matthews. (2019) In silico scaling and prioritization of chemical disposition and chemical toxicity of 15,145 organic chemicals. Computational Toxicology 9, pages 100-132.
Crossref
Darren V. S. Green. 2019. Machine Learning in Chemistry: Data-Driven Algorithms, Learning Systems, and Predictions. Machine Learning in Chemistry: Data-Driven Algorithms, Learning Systems, and Predictions
81
101
.
Rafael Gozalbes & Jesús Vicente de Julián-Ortiz. (2018) Applications of Chemoinformatics in Predictive Toxicology for Regulatory Purposes, Especially in the Context of the EU REACH Legislation. International Journal of Quantitative Structure-Property Relationships 3:1, pages 1-24.
Crossref
John C. Dearden. 2017. Oncology. Oncology
67
117
.
D. Armstrong, S. Li, W. Frieauff, H.-J. Martus, J. Reilly, D. Mikhailov, S. Whitebread & L. Urban. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
94
115
.
Prachi Pradeep, Richard J. Povinelli, Shannon White & Stephen J. Merrill. (2016) An ensemble model of QSAR tools for regulatory risk assessment. Journal of Cheminformatics 8:1.
Crossref
Caroline L. Pinto, Kamel Mansouri, Richard Judson & Patience Browne. (2016) Prediction of Estrogenic Bioactivity of Environmental Chemical Metabolites. Chemical Research in Toxicology 29:9, pages 1410-1427.
Crossref
Ambavaram Vijaya Bhaskar Reddy, Jafariah Jaafar, Khalid Umar, Zaiton Abdul Majid, Azmi Bin Aris, Juhaizah Talib & Gajulapalle Madhavi. (2015) Identification, control strategies, and analytical approaches for the determination of potential genotoxic impurities in pharmaceuticals: A comprehensive review. Journal of Separation Science 38:5, pages 764-779.
Crossref
April Neal-Kluever, Jason Aungst, Yan Gu, Karen Hatwell, Kristi Muldoon-Jacobs, Ayesha Liem, Adejoke Ogungbesan & Mary Shackelford. (2014) Infant toxicology: State of the science and considerations in evaluation of safety. Food and Chemical Toxicology 70, pages 68-83.
Crossref
Aleksandra Rybacka, Christina Rudén & Patrik L. Andersson. (2014)
On the Use of
In Silico
Tools for Prioritising Toxicity Testing of the Low-Volume Industrial Chemicals in REACH
. Basic & Clinical Pharmacology & Toxicology 115:1, pages 77-87.
Crossref
M.L. Peach, A.V. Zakharov, L. Guasch & M.C. Nicklaus. 2014. Comprehensive Biomedical Physics. Comprehensive Biomedical Physics
123
156
.
Alexey Zakharov & Alexey Lagunin. 2014. Application of Computational Techniques in Pharmacy and Medicine. Application of Computational Techniques in Pharmacy and Medicine
325
367
.
Jordi Quintana, Antoni Valencia & Josep ProusJr.Jr.. 2013. Data Mining in Drug Discovery. Data Mining in Drug Discovery
209
240
.
Alexis D. C. Parenty, William G. Button & Martin A. Ott. (2013) An Expert System To Predict the Forced Degradation of Organic Molecules. Molecular Pharmaceutics 10:8, pages 2962-2974.
Crossref
Nigel Greene & Mark Gosink. 2013. Computational Toxicology. Computational Toxicology
171
193
.
Luis G. ValerioJr.Jr.. 2013. Computational Toxicology. Computational Toxicology
85
112
.
Alexander Amberg. 2013. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
1273
1296
.
Luis G. ValerioJr.Jr.. 2013. Computational Toxicology. Computational Toxicology
341
354
.
Luis G. ValerioJrJr & Supratim Choudhuri. (2012)
Chemoinformatics and chemical genomics: potential utility of
in silico
methods
. Journal of Applied Toxicology 32:11, pages 880-889.
Crossref
Amabel M. Orogo, Sydney S. Choi, Barbara L. Minnier & Naomi L. Kruhlak. (2012) Construction and Consensus Performance of (Q)SAR Models for Predicting Phospholipidosis Using a Dataset of 743 Compounds. Molecular Informatics 31:10, pages 725-739.
Crossref
Krista L. Dobo, Nigel Greene, Charlotta Fred, Susanne Glowienke, James S. Harvey, Catrin Hasselgren, Robert Jolly, Michelle O. Kenyon, Jennifer B. Munzner, Wolfgang Muster, Robin Neft, M. Vijayaraj Reddy, Angela T. White & Sandy Weiner. (2012) In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: An industry survey. Regulatory Toxicology and Pharmacology 62:3, pages 449-455.
Crossref
N L Kruhlak, R D Benz, H Zhou & T J Colatsky. (2012) (Q)SAR Modeling and Safety Assessment in Regulatory Review. Clinical Pharmacology & Therapeutics 91:3, pages 529-534.
Crossref
Melinda I. Sosa, Clinton Maddox, Iestyn Lewis, Cheryl L. Meyerkord & Pahk Thepchatri. 2012. Chemical Genomics. Chemical Genomics
137
156
.
Haslan Roslie, Kok Meng Chan, Nor Fadilah Rajab, Saraswathi S. Velu, Syed Abd. Illah Alyahya Syed Abd. Kadir, Irmaizatussyehdany Bunyamin, Jean-Frédéric Faizal Weber, Noel F. Thomas, Abu Bakar Abdul Majeed, Glenn Myatt & Salmaan Hussain Inayat-Hussain. (2012) 3,5-Dibenzyloxy-4'-hydroxystilbene induces early caspase-9 activation during apoptosis in human K562 chronic myelogenous leukemia cells. The Journal of Toxicological Sciences 37:1, pages 13-21.
Crossref
Supratim Choudhuri, Kirk Arvidson & Ronald Chanderbhan. 2012. Veterinary Toxicology. Veterinary Toxicology
406
425
.
Robert D. Combes. 2012. New Technologies for Toxicity Testing. New Technologies for Toxicity Testing
96
116
.
Nigel Greene & Minghu Song. (2011)
Predicting
in vivo
safety characteristics using physiochemical properties and
in vitro
assays
. Future Medicinal Chemistry 3:12, pages 1503-1511.
Crossref
Elena Lo Piparo, Andrew Worth, Mary Manibusan, Chihae Yang, Benoît Schilter, Paolo Mazzatorta, Miriam N. Jacobs, Hans Steinkellner & Luc Mohimont. (2011) Use of computational tools in the field of food safety. Regulatory Toxicology and Pharmacology 60:3, pages 354-362.
Crossref
Brinda Mahadevan, Ronald D. Snyder, Michael D. Waters, R.Daniel Benz, Raymond A. Kemper, Raymond R. Tice & Ann M. Richard. (2011) Genetic toxicology in the 21st century: Reflections and future directions. Environmental and Molecular Mutagenesis 52:5, pages 339-354.
Crossref
Antonio Giordani, Werner Kobel & Hans Ulrich Gally. (2011) Overall impact of the regulatory requirements for genotoxic impurities on the drug development process. European Journal of Pharmaceutical Sciences 43:1-2, pages 1-15.
Crossref
Sarah Adler, David Basketter, Stuart Creton, Olavi Pelkonen, Jan van Benthem, Valérie Zuang, Klaus Ejner Andersen, Alexandre Angers-Loustau, Aynur Aptula, Anna Bal-Price, Emilio Benfenati, Ulrike Bernauer, Jos Bessems, Frederic Y. Bois, Alan Boobis, Esther Brandon, Susanne Bremer, Thomas Broschard, Silvia Casati, Sandra Coecke, Raffaella Corvi, Mark Cronin, George Daston, Wolfgang Dekant, Susan Felter, Elise Grignard, Ursula Gundert-Remy, Tuula Heinonen, Ian Kimber, Jos Kleinjans, Hannu Komulainen, Reinhard Kreiling, Joachim Kreysa, Sofia Batista Leite, George Loizou, Gavin Maxwell, Paolo Mazzatorta, Sharon Munn, Stefan Pfuhler, Pascal Phrakonkham, Aldert Piersma, Albrecht Poth, Pilar Prieto, Guillermo Repetto, Vera Rogiers, Greet Schoeters, Michael Schwarz, Rositsa Serafimova, Hanna Tähti, Emanuela Testai, Joost van Delft, Henk van Loveren, Mathieu Vinken, Andrew Worth & José-Manuel Zaldivar. (2011) Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010. Archives of Toxicology 85:5, pages 367-485.
Crossref
Joseph F. Contrera. (2011) Improved in silico prediction of carcinogenic potency (TD50) and the risk specific dose (RSD) adjusted Threshold of Toxicological Concern (TTC) for genotoxic chemicals and pharmaceutical impurities. Regulatory Toxicology and Pharmacology 59:1, pages 133-141.
Crossref
Yun-Jan Wang, Jinhui Dou, Kevin P. Cross & Luis G. ValerioJr.Jr.. (2011) Computational analysis for hepatic safety signals of constituents present in botanical extracts widely used by women in the United States for treatment of menopausal symptoms. Regulatory Toxicology and Pharmacology 59:1, pages 111-124.
Crossref
Richard M. Walmsley & David Elder. 2011. ADMET for Medicinal Chemists. ADMET for Medicinal Chemists
315
352
.
. 2010. Risk Assessment of Phytochemicals in Food. Risk Assessment of Phytochemicals in Food
38
159
.
Anuradha Garg, Dennis W. Solas, Lori H. Takahashi & James V. Cassella. (2010) Forced degradation of fentanyl: Identification and analysis of impurities and degradants. Journal of Pharmaceutical and Biomedical Analysis 53:3, pages 325-334.
Crossref
Ovanes MekenyanM. T. D. Cronin & J. C. Madden. 2010. In Silico Toxicology. In Silico Toxicology
606
623
.
Ovanes MekenyanJ. C. Dearden. 2010. In Silico Toxicology. In Silico Toxicology
478
507
.
Joel P. Bercu, Stuart M. Morton, J. Thom Deahl, Vijay K. Gombar, Courtney M. Callis & Robert B.L. van Lier. (2010) In silico approaches to predicting cancer potency for risk assessment of genotoxic impurities in drug substances. Regulatory Toxicology and Pharmacology 57:2-3, pages 300-306.
Crossref
Anna A. Frid & Edwin J. Matthews. (2010) Prediction of drug-related cardiac adverse effects in humans-B: Use of QSAR programs for early detection of drug-induced cardiac toxicities. Regulatory Toxicology and Pharmacology 56:3, pages 276-289.
Crossref
Markus K. Dahlgren, Caroline E. Zetterström, Åsa Gylfe, Anna Linusson & Mikael Elofsson. (2010) Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium Yersinia. Bioorganic & Medicinal Chemistry 18:7, pages 2686-2703.
Crossref
Luis G. ValerioJr.Jr., Kirk B. Arvidson, Emily Busta, Barbara L. Minnier, Naomi L. Kruhlak & R. Daniel Benz. (2010) Testing computational toxicology models with phytochemicals. Molecular Nutrition & Food Research 54:2, pages 186-194.
Crossref
Claire M. Ellison, Judith C. Madden, Philip Judson & Mark T. D. Cronin. (2010) Using In Silico Tools in a Weight of Evidence Approach to Aid Toxicological Assessment. Molecular Informatics 29:1-2, pages 97-110.
Crossref
Wendy A. Warr. 2011. Chemoinformatics and Computational Chemical Biology. Chemoinformatics and Computational Chemical Biology
1
37
.
Mark T. D. Cronin. 2010. Recent Advances in QSAR Studies. Recent Advances in QSAR Studies
305
325
.
Chihae Yang, Luis G. ValerioJrJr & Kirk B. Arvidson. (2009) Computational Toxicology Approaches at the US Food and Drug Administration. Alternatives to Laboratory Animals 37:5, pages 523-531.
Crossref
Richard M Walmsley & Nicholas Billinton. 2009. Hit and Lead Profiling. Hit and Lead Profiling
241
271
.
Steven J. Enoch, Mark T. D. Cronin, Judith C. Madden & Mark Hewitt. (2009) Formation of Structural Categories to Allow for Read-Across for Teratogenicity. QSAR & Combinatorial Science 28:6-7, pages 696-708.
Crossref
Edwin J. Matthews, Carling J. Ursem, Naomi L. Kruhlak, R. Daniel Benz, David Aragonés Sabaté, Chihae Yang, Gilles Klopman & Joseph F. Contrera. (2009) Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities. Regulatory Toxicology and Pharmacology 54:1, pages 23-42.
Crossref
Edwin J. Matthews, Naomi L. Kruhlak, R. Daniel Benz, David Aragonés Sabaté, Carol A. Marchant & Joseph F. Contrera. (2009) Identification of structure–activity relationships for adverse effects of pharmaceuticals in humans: Part C: Use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicities. Regulatory Toxicology and Pharmacology 54:1, pages 43-65.
Crossref
Carling J. Ursem, Naomi L. Kruhlak, Joseph F. Contrera, Philip M. MacLaughlin, R. Daniel Benz & Edwin J. Matthews. (2009) Identification of structure–activity relationships for adverse effects of pharmaceuticals in humans. Part A: Use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicities. Regulatory Toxicology and Pharmacology 54:1, pages 1-22.
Crossref
Arturo Anadón, Maria Rosa Martínez-Larrañaga & Luis G. ValerioJr.Jr.. 2009. Handbook of Toxicology of Chemical Warfare Agents. Handbook of Toxicology of Chemical Warfare Agents
143
152
.
LG Valerio. (2008) Tools for evidence-based toxicology: computational-based strategies as a viable modality for decision support in chemical safety evaluation and risk assessment. Human & Experimental Toxicology 27:10, pages 757-760.
Crossref